NCT02792075 Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
| NCT ID | NCT02792075 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seung-Jung Park |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2016-07 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2016-07 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the prognosis of coronary stenosis based on intracoronary Imaging.
Eligibility Criteria
Inclusion Criteria: * Patients with intracoronary imaging * Written consent Exclusion Criteria: * Severe calcification and/or severe tortuosity * Lesion with previous bypass graft surgery (CABG) * Left ventricular ejection fraction less than 30 % * Coronary spasm * Life expectancy less than 2 years * Pregnancy or breast-feeding
Contact & Investigator
Seung-jung Park, MD
✉ sjpark@amc.seoul.krFrequently Asked Questions
Who can join the NCT02792075 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02792075 currently recruiting?
Yes, NCT02792075 is actively recruiting participants. Contact the research team at sjpark@amc.seoul.kr for enrollment information.
Where is the NCT02792075 trial being conducted?
This trial is being conducted at Seoul, South Korea, Busan, South Korea, Cheonan, South Korea, Daegu, South Korea and 11 additional locations.
Who is sponsoring the NCT02792075 clinical trial?
NCT02792075 is sponsored by Seung-Jung Park. The trial plans to enroll 4,000 participants.